Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Cardiology

Serious Complications: Heart Health and Carcinoid Crisis

At a Glance

Carcinoid syndrome can damage the heart’s right-sided valves over time and can cause a sudden, life-threatening hormone surge called carcinoid crisis. Regular heart screening and a procedure-specific octreotide plan help patients and care teams respond quickly.

While most symptoms of Carcinoid Syndrome are manageable with daily treatment, there are two serious complications that every patient must understand: Carcinoid Heart Disease (CHD) and Carcinoid Crisis [1][2]. These conditions require specialized monitoring and, in some cases, immediate emergency care [3][1].

Carcinoid Heart Disease (CHD)

Carcinoid Heart Disease is a unique form of heart damage caused by long-term exposure to high levels of serotonin and other chemicals [4][5]. These substances can cause plaque-like deposits to form on the valves on the right side of the heart—the tricuspid and pulmonary valves [5][6].

Over time, this causes the valves to become thick, retracted, and stiff, preventing them from opening or closing properly [5]. This makes it harder for the heart to pump blood to the lungs, leading to right-sided heart failure [5][7]. Because early damage often causes no symptoms, screening should begin as soon as Carcinoid Syndrome is diagnosed [4][1].

The Standard Screening Protocol:

  • NT-proBNP: A simple blood test that measures a protein released when the heart is under stress [4]. An elevated level is often used as a signal that the heart needs a closer look, though this is interpreted with symptoms and exams, not as a strict diagnostic cutoff [1][8].
  • Echocardiogram (TTE): An ultrasound of the heart to look for valve thickening or leakage [5][9]. Specialists recommend regular, serial “echoes” because heart disease can develop even years after your initial diagnosis [10][9].
  • 5-HIAA Monitoring: Higher levels of 5-HIAA in your urine or blood are strongly linked to an increased risk of developing heart complications [10][11].

Carcinoid Crisis: A Medical Emergency

A Carcinoid Crisis is a sudden, life-threatening surge of symptoms caused by a massive release of hormones [2][12]. This leads to dangerous instability in your blood pressure and heart rate [2].

Common Triggers:

  • Surgery or Anesthesia: The physical stress of an operation or certain anesthetic drugs can trigger a release [13][2].
  • Tumor Manipulation: Procedures like a biopsy or liver-directed therapy (embolization) can physically stress the tumor, risking a hormone dump [14][15].
  • Systemic Treatment: Occasionally, the first dose of PRRT (Lutathera) can cause a flare or crisis [16][17].

To prevent this, specialized centers use a multidisciplinary crisis protocol during procedures, which may involve having short-acting IV octreotide immediately available or running a continuous IV drip of octreotide to keep hormone levels stable, along with close hemodynamic monitoring [18][19]. Ensure you tell every surgeon and anesthesiologist about your diagnosis beforehand.

When to Seek Urgent Medical Care

Knowing the difference between a typical “flare” and a dangerous complication is vital. You should create an individualized action plan with your care team.

Call Your Doctor For Prompt Assessment For:

  • An increase in diarrhea frequency that causes signs of dehydration (like markedly reduced urination or an inability to keep fluids down) [20].
  • New or worsening swelling in your ankles or legs [21].
  • Needing to use your “rescue” octreotide significantly more often than your normal baseline [22].

Go to the Emergency Room or Call 911 For:

  • Severe Hypotension: Feeling profoundly dizzy, fainting, or being unable to stand up safely [3][2].
  • Severe Breathing Issues: Extreme wheezing, chest tightness, or a blue tint to the lips (cyanosis) [2][7].
  • Obstructive Symptoms: Sharp, severe abdominal pain accompanied by vomiting or an inability to pass gas or stool [23][24].
  • Acute Heart Failure: Sudden, severe shortness of breath, rapidly worsening breathlessness, or chest pain [7][25].

Always carry a “medical alert” card or wear a bracelet that identifies you have Carcinoid Syndrome and may require emergency IV octreotide during a crisis [3][2].

Common questions in this guide

What is carcinoid heart disease, and why is it serious?
Carcinoid heart disease is damage to the heart’s right-sided valves caused by long-term exposure to high levels of serotonin and other chemicals. The tricuspid and pulmonary valves can become thick and stiff, making it harder for the heart to pump blood to the lungs and potentially leading to right-sided heart failure.
Which tests monitor my risk for carcinoid heart disease?
Doctors may use an NT-proBNP blood test and an echocardiogram, which is an ultrasound of the heart, to look for signs of heart strain or valve damage. They may also track 5-HIAA in urine or blood because higher levels are linked with a greater risk of heart complications. Results are interpreted with your symptoms and examination rather than by a single number alone.
What can cause a carcinoid crisis?
A carcinoid crisis is a sudden, life-threatening surge of hormones that can make blood pressure and heart rate dangerously unstable. Surgery, anesthesia, tumor manipulation during a biopsy or liver-directed procedure, and sometimes the first dose of PRRT can trigger it.
How can a carcinoid crisis be managed during a procedure?
The care team should know about your carcinoid syndrome before surgery, anesthesia, biopsy, liver-directed therapy, or PRRT. A specialized protocol may include short-acting intravenous octreotide ready for immediate use or a continuous octreotide infusion, along with close monitoring of blood pressure and heart rate.
What symptoms mean I should seek emergency help?
Call emergency services for profound dizziness or fainting, severe breathing trouble, extreme wheezing, chest tightness, blue lips, sudden severe shortness of breath, or chest pain. Severe abdominal pain with vomiting or inability to pass gas or stool is also an emergency because it may signal an obstruction.
When should I contact my doctor about worsening carcinoid syndrome symptoms?
Contact your doctor promptly if diarrhea is becoming frequent enough to cause dehydration, if you cannot keep fluids down, if new ankle or leg swelling appears, or if you need rescue octreotide more often than usual. Your care team can help distinguish a manageable flare from a complication that needs urgent evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Have I had a baseline NT-proBNP blood test and an echocardiogram to check for Carcinoid Heart Disease?
  2. 2.What is my current 24-hour urinary 5-HIAA level, and does it put me at a higher risk for heart complications?
  3. 3.If I need surgery or a procedure like a biopsy or PRRT, what is the specific, individualized plan to prevent and manage a carcinoid crisis?
  4. 4.Should I have a 'rescue' dose of octreotide at home, and when exactly should I use it versus going to the emergency room?
  5. 5.Do you have experience managing Carcinoid Heart Disease, or should I be referred to a specialized cardio-oncology team?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Carcinoid Heart Disease: A Review.

    Hayes AR, Davar J, Caplin ME

    Endocrinology and metabolism clinics of North America 2018; (47(3)):671-682 doi:10.1016/j.ecl.2018.04.012.

    PMID: 30098723
  2. 2

    Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

    Maxwell JE, Naraev B, Halperin DM, et al.

    Annals of surgical oncology 2022; (29(5)):3072-3084 doi:10.1245/s10434-022-11371-0.

    PMID: 35165817
  3. 3

    Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency.

    Bardasi C, Benatti S, Luppi G, et al.

    Cancers 2022; (14(3)) doi:10.3390/cancers14030662.

    PMID: 35158931
  4. 4

    Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.

    Das S, Stockton SS, Hassan SA

    The oncologist 2023; (28(7)):575-583 doi:10.1093/oncolo/oyad126.

    PMID: 37209415
  5. 5

    What do we know about carcinoid heart disease in the present era?

    Pęczkowska M, Konsek-Komorowska SJ, Kolasińska-Ćwikła AD, et al.

    Kardiologia polska 2022; (80(10)):990-1001 doi:10.33963/KP.a2022.0222.

    PMID: 36136036
  6. 6

    From Carcinoid Syndrome to Carcinoid Heart Disease: The Cost of Delayed Cardiac Surveillance.

    Ballas CE, Tourmousoglou C, Arseniou A, Kolettis TM

    Cureus 2026; (18(7)):e112770 doi:10.7759/cureus.112770.

    PMID: 42604232
  7. 7

    Carcinoid heart disease of gonadal primary presenting with hypoxia: a case report.

    O'Driscoll R, Prashar A, Youssef G, Sader M

    European heart journal. Case reports 2021; (5(5)):ytaa536 doi:10.1093/ehjcr/ytaa536.

    PMID: 34124556
  8. 8

    Screening for carcinoid heart disease: Trends and future Perspectives.

    Mouser B, Howe JR, Atari O, et al.

    International journal of cardiology. Cardiovascular risk and prevention 2024; (22()):200293 doi:10.1016/j.ijcrp.2024.200293.

    PMID: 38911359
  9. 9

    Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).

    Hofland J, Lamarca A, Steeds R, et al.

    Journal of neuroendocrinology 2022; (34(3)):e13060 doi:10.1111/jne.13060.

    PMID: 34825753
  10. 10

    Progression of Carcinoid Heart Disease in the Modern Management Era.

    Baron E, Szymanski C, Hergault H, et al.

    Journal of the American Heart Association 2021; (10(23)):e020475 doi:10.1161/JAHA.120.020475.

    PMID: 34816734
  11. 11

    The role of N-terminal pro-brain natriuretic peptide, chromogranin A, and 5-hydroxyindoleacetic acid in screening for carcinoid heart disease.

    Johnson KKN, Stemann Lau T, Mark Dahl Baunwall S, et al.

    Journal of neuroendocrinology 2023; (35(10)):e13327 doi:10.1111/jne.13327.

    PMID: 37574797
  12. 12

    Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome.

    Clement D, Ramage J, Srirajaskanthan R

    Journal of oncology 2020; (2020()):8341426 doi:10.1155/2020/8341426.

    PMID: 32322270
  13. 13

    Perioperative Carcinoid Crisis: A Systematic Review and Meta-Analysis.

    Xu A, Suz P, Reljic T, et al.

    Cancers 2022; (14(12)) doi:10.3390/cancers14122966.

    PMID: 35740631
  14. 14

    Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases.

    Kwon DH, Paciorek A, Mulvey CK, et al.

    Pancreas 2019; (48(4)):496-503 doi:10.1097/MPA.0000000000001271.

    PMID: 30946246
  15. 15

    Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes.

    Kinney MAO, Nagorney DM, Clark DF, et al.

    Journal of clinical anesthesia 2018; (51()):93-96 doi:10.1016/j.jclinane.2018.08.005.

    PMID: 30098573
  16. 16

    Carcinoid crisis in Lutetium-177-Dotatate therapy of neuroendocrine tumors: an overview of pathophysiology, risk factors, recognition, and treatment.

    Sozio SJ, Raynor W, Becker MC, et al.

    EJNMMI reports 2024; (8(1)):29 doi:10.1186/s41824-024-00216-6.

    PMID: 39266864
  17. 17

    Prevention and management of carcinoid crises in patients with high-risk neuroendocrine tumours undergoing peptide receptor radionuclide therapy (PRRT): Literature review and case series from two Australian tertiary medical institutions.

    Tapia Rico G, Li M, Pavlakis N, et al.

    Cancer treatment reviews 2018; (66()):1-6 doi:10.1016/j.ctrv.2018.03.002.

    PMID: 29602040
  18. 18

    Pharmacology of Octreotide: Clinical Implications for Anesthesiologists and Associated Risks.

    Borna RM, Jahr JS, Kmiecik S, et al.

    Anesthesiology clinics 2017; (35(2)):327-339 doi:10.1016/j.anclin.2017.01.021.

    PMID: 28526153
  19. 19

    [Multimodal therapy improved carcinoid syndrome secondary to liver metastases of an atypical lung carcinoid tumor:a case report].

    Shimizu T, Adikrisna R, Shimada K, et al.

    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2020; (117(7)):635-645 doi:10.11405/nisshoshi.117.635.

    PMID: 32655123
  20. 20

    TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.

    Strosberg J, Joish VN, Giacalone S, et al.

    The oncologist 2019; (24(11)):1446-1452 doi:10.1634/theoncologist.2018-0921.

    PMID: 31189618
  21. 21

    Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management.

    Jin C, Sharma AN, Thevakumar B, et al.

    Cardiology 2021; (146(1)):65-73 doi:10.1159/000507847.

    PMID: 33070143
  22. 22

    Management of carcinoid syndrome: a systematic review and meta-analysis.

    Hofland J, Herrera-Martínez AD, Zandee WT, de Herder WW

    Endocrine-related cancer 2019; (26(3)):R145-R156.

    PMID: 30608900
  23. 23

    Surgical Management of Primary Small Bowel NET Presenting Acutely with Obstruction or Perforation.

    Rajaretnam NS, Meyer-Rochow GY,

    World journal of surgery 2021; (45(1)):203-207 doi:10.1007/s00268-020-05689-7.

    PMID: 32696097
  24. 24

    Surgical Treatment of Small Bowel Neuroendocrine Tumors.

    Farley HA, Pommier RF

    Hematology/oncology clinics of North America 2016; (30(1)):49-61.

    PMID: 26614368
  25. 25

    Carcinoid Heart Disease: a Comprehensive Review.

    Hassan SA, Palaskas NL, Agha AM, et al.

    Current cardiology reports 2019; (21(11)):140 doi:10.1007/s11886-019-1207-8.

    PMID: 31745664

This page is for informational purposes only and does not constitute medical advice. Discuss your heart screening and procedure-specific emergency plan with your oncology and cardiology teams, and seek emergency care for severe symptoms.

Get notified when new evidence is published on Carcinoid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.